Nokia Corporation (ADR) (NYSE:NOK) and Airtel have joined hands to offer Nokia XL users across India free Android app downloads as part of a plan to encourage data usage and treat owners of the smartphone simultaneously. Going by the details of the deal, subscribers will be able to download applications onto their handset for free. Nokia Corporation (ADR) (NYSE:NOK) net profit margin is -9.50% and weekly performance is 1.01%. On last trading day company shares ended up $7.98. Analysts mean target price for the company is $8.23. Nokia Corporation (ADR) (NYSE:NOK) distance from 50-day simple moving average (SMA50) is 5.65%.
Ericsson (ADR) (NASDAQ:ERIC) will coordinate and manage playout for the six radio stations while prioritizing quality, continuity, efficiency and innovation NPO and Ericsson continue their longstanding relationship, benefitting the national broadcaster`s listeners Netherlands Public Broadcasting (NPO) has signed a six-year radio services contract extension with Ericsson (ERIC). Ericsson (ADR) (NASDAQ:ERIC) shares fell -0.98% in last trading session and ended the day on $12.09. Gross Margin is 35.50% and its return on assets is 4.90%. Ericsson (ADR) (NASDAQ:ERIC) quarterly performance is -2.26%.
On June 13, Equities research analysts at Barclays assumed coverage on shares of National Bank of Greece (ADR) (NYSE:NBG) in a research note issued to investors on Wednesday. The firm set an “equal weight” rating on the stock. National Bank of Greece (ADR) (NYSE:NBG) shares moved down -0.26% in last trading session and was closed at $3.77, while trading in range of $3.74 – $3.80. National Bank of Greece (ADR) (NYSE:NBG) year to date (YTD) performance is -32.68%.
Metlife Inc (NYSE:MET) CAO Peter M. Carlson unloaded 91,625 shares of the stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $54.29, for a total transaction of $4,974,321.25. Following the completion of the sale, the chief accounting officer now directly owns 15,015 shares of the company’s stock, valued at approximately $815,164. Metlife Inc (NYSE:MET) ended the last trading day at $54.44. Company weekly volatility is calculated as 1.25% and price to cash ratio as 7.15. Metlife Inc (NYSE:MET) showed a negative weekly performance of -0.40%.
Biogen Idec(BIIB) and AbbVie Inc (NYSE:ABBV) announced positive top-line results from the Phase 3 DECIDE clinical trial, designed to evaluate the superiority of once-monthly, subcutaneous daclizumab high-yield process (DAC HYP) when compared to intramuscular interferon beta-1a (IFN β-1a), as a potential treatment for relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS). AbbVie Inc (NYSE:ABBV) net profit margin is 21.80% and weekly performance is 0.30%. On last trading day company shares ended up $54.00. Analysts mean target price for the company is $57.10. AbbVie Inc (NYSE:ABBV) distance from 50-day simple moving average (SMA50) is 4.07%.